Global Wealth Management Investment Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-107
Closed -$7K 270
2022
Q2
$7K Buy
107
+54
+102% +$3.34K ﹤0.01% 314
2022
Q1
$3K Buy
53
+23
+77% +$1.47K ﹤0.01% 389
2021
Q4
$2K Hold
30
﹤0.01% 401
2021
Q3
$2K Hold
30
﹤0.01% 412
2021
Q2
$2K Sell
30
-50
-63% -$3.34K ﹤0.01% 390
2021
Q1
$5K Hold
80
﹤0.01% 355
2020
Q4
$5K Sell
80
-55
-41% -$3.32K ﹤0.01% 329
2020
Q3
$9K Sell
135
-253
-65% -$17.5K ﹤0.01% 280
2020
Q2
$30K Buy
388
+155
+67% +$11.9K 0.01% 236
2020
Q1
$17K Buy
233
+53
+29% +$3.66K 0.01% 272
2019
Q4
$12K Buy
180
+58
+48% +$3.78K 0.01% 326
2019
Q3
$8K Sell
122
-11
-8% -$719 ﹤0.01% 348
2019
Q2
$9K Sell
133
-239
-64% -$15.7K ﹤0.01% 381
2019
Q1
$24K Hold
372
0.01% 284
2018
Q4
$23K Buy
+372
New +$26K 0.01% 283

Other funds holding GILD

Global Wealth Management Investment Advisory's GILD Position: Q3 2022 in Review

Global Wealth Management Investment Advisory sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 107 shares — an estimated $7K sold.

Global Wealth Management Investment Advisory first reported a position in GILD in Q4 2018 and held it in 15 quarters. The position peaked at $30K in Q2 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Global Wealth Management Investment Advisory reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 107 Gilead Sciences shares in Q3 2022, an estimated $7K.
  • Global Wealth Management Investment Advisory first reported a position in Gilead Sciences in Q4 2018 and held it in 15 quarters.
  • Global Wealth Management Investment Advisory's Gilead Sciences position peaked at $30K in Q2 2020.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2022, filed 19 Oct 2022.